JP2023518776A5 - - Google Patents

Info

Publication number
JP2023518776A5
JP2023518776A5 JP2022556477A JP2022556477A JP2023518776A5 JP 2023518776 A5 JP2023518776 A5 JP 2023518776A5 JP 2022556477 A JP2022556477 A JP 2022556477A JP 2022556477 A JP2022556477 A JP 2022556477A JP 2023518776 A5 JP2023518776 A5 JP 2023518776A5
Authority
JP
Japan
Prior art keywords
formula
compound
copper
salt
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022556477A
Other languages
English (en)
Japanese (ja)
Other versions
JP7761578B2 (ja
JP2023518776A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/083016 external-priority patent/WO2021190604A1/en
Publication of JP2023518776A publication Critical patent/JP2023518776A/ja
Publication of JP2023518776A5 publication Critical patent/JP2023518776A5/ja
Application granted granted Critical
Publication of JP7761578B2 publication Critical patent/JP7761578B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022556477A 2020-03-26 2021-03-25 シクロスポリン誘導体の調製 Active JP7761578B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CNPCT/CN2020/081295 2020-03-26
CN2020081295 2020-03-26
CN2021078391 2021-03-01
CNPCT/CN2021/078391 2021-03-01
PCT/CN2021/083016 WO2021190604A1 (en) 2020-03-26 2021-03-25 Preparation of cyclosporin derivatives

Publications (3)

Publication Number Publication Date
JP2023518776A JP2023518776A (ja) 2023-05-08
JP2023518776A5 true JP2023518776A5 (cg-RX-API-DMAC10.html) 2024-04-05
JP7761578B2 JP7761578B2 (ja) 2025-10-28

Family

ID=77891510

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022556477A Active JP7761578B2 (ja) 2020-03-26 2021-03-25 シクロスポリン誘導体の調製
JP2022556478A Active JP7776435B2 (ja) 2020-03-26 2021-03-25 シクロフィリン阻害剤およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022556478A Active JP7776435B2 (ja) 2020-03-26 2021-03-25 シクロフィリン阻害剤およびその使用

Country Status (13)

Country Link
US (3) US12673976B2 (cg-RX-API-DMAC10.html)
EP (2) EP4126905B1 (cg-RX-API-DMAC10.html)
JP (2) JP7761578B2 (cg-RX-API-DMAC10.html)
KR (2) KR20220158760A (cg-RX-API-DMAC10.html)
CN (2) CN115335389A (cg-RX-API-DMAC10.html)
AU (1) AU2021240762A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022018929A2 (cg-RX-API-DMAC10.html)
CA (2) CA3172535A1 (cg-RX-API-DMAC10.html)
ES (1) ES3074820T3 (cg-RX-API-DMAC10.html)
IL (1) IL296586B2 (cg-RX-API-DMAC10.html)
MX (1) MX2022011697A (cg-RX-API-DMAC10.html)
TW (1) TWI917366B (cg-RX-API-DMAC10.html)
WO (2) WO2021190601A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111449050A (zh) * 2019-01-20 2020-07-28 睿诺医疗科技(上海)有限公司 环孢菌素类似物及其用途
CN116870135A (zh) 2019-10-12 2023-10-13 睿诺医疗科技(上海)有限公司 肾毒素诱发的肾损伤的治疗和预防
CA3172535A1 (en) 2020-03-26 2021-09-30 Ching-Pong Mak Cyclophilin inhibitors and uses thereof
AU2021256222A1 (en) 2020-04-15 2022-10-06 Farsight Medical Technology (Shanghai) Co., Ltd. Prevention and treatment of organ injuries
GB202207348D0 (en) * 2022-05-19 2022-07-06 Cypralis Ltd Macrocyclic compounds and uses thereof
TW202438040A (zh) * 2023-03-03 2024-10-01 大陸商睿諾醫療科技(上海)有限公司 劑誘導的肝臟病症或疾病的治療和預防
WO2024245384A1 (en) * 2023-06-02 2024-12-05 Farsight Medical Technology (Shanghai) Co., Ltd. Cyclophilin inhibitors and uses thereof
WO2026119135A1 (en) * 2024-12-03 2026-06-11 Farsight Medical Technology (Shanghai) Co., Ltd. Cyclophilin inhibitors and uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
FI111730B (fi) 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
DE69832984T2 (de) * 1997-10-08 2006-09-21 Isotechnika, Inc., Edmonton DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN
ATE254630T1 (de) 1998-06-12 2003-12-15 Chem Ag C Cyclosporine
US6809077B2 (en) 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
DK1436322T3 (da) 2001-10-19 2008-11-03 Isotechnika Inc Blandinger af cyclosporinanaloger og deres anvendelse som immunmodulerende midler
CA2518265A1 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
JP2007532507A (ja) * 2004-04-08 2007-11-15 ノバルティス アクチエンゲゼルシャフト 脳虚血ならびに脳および脊髄傷害の処置のためのサイクロスポリンの使用
PT1802650E (pt) * 2004-10-01 2011-12-30 Scynexis Inc Derivados da ciclosporina 3-éter e 3-tioéter substituída para o tratamento e prevenção da infecção de hepatite c
CN101068829B (zh) * 2004-10-01 2012-05-30 西尼克斯公司 用于治疗和预防丙型肝炎病毒感染的3-醚和3-硫醚取代的环孢菌素衍生物
CA2652662C (en) * 2006-05-19 2015-11-03 Scynexis, Inc. Methods for the treatment and prevention of ocular disorders
WO2008143996A1 (en) * 2007-05-18 2008-11-27 Scynexis, Inc. New chemical processes
MX2011001152A (es) 2008-07-30 2011-06-09 Isotechnika Pharma Inc Moleculas de analogo de ciclosporina no-inmunesupresoras.
RU2492181C2 (ru) 2009-01-30 2013-09-10 Энанта Фармасьютикалс, Инк. Аналоги циклоспорина для предупреждения или лечения инфекции гепатита с
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
CA2785978A1 (en) * 2009-12-30 2011-07-07 Scynexis, Inc. Cyclosporine analogues
US9217015B2 (en) 2010-07-16 2015-12-22 S&T Global Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
AU2011342284C1 (en) 2010-12-15 2017-07-13 Contravir Pharmaceuticals, Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
DE102011111991A1 (de) 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
GB201217560D0 (en) 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
US20140213508A1 (en) 2012-10-19 2014-07-31 Scynexis, Inc. Antiviral macrocycles
GB201222455D0 (en) 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
GB201414806D0 (en) 2014-08-20 2014-10-01 Ucl Business Plc Cyclosporin conjugates
CN108025039B (zh) 2015-06-30 2022-07-29 西普拉里斯有限公司 新颖的大环化合物
CN106902347A (zh) * 2015-12-23 2017-06-30 中美华世通生物医药科技(武汉)有限公司 亲环孢素抑制剂的用途
CN106902346A (zh) 2015-12-23 2017-06-30 中美华世通生物医药科技(武汉)有限公司 药物组合物及其制药用途
AU2017267560B2 (en) * 2016-05-17 2022-03-24 S&T Global Inc. Novel cyclosporin derivatives and uses thereof
GB201711749D0 (en) * 2017-07-21 2017-09-06 Cypralis Ltd Cyclosporin analogues and uses thereof
WO2020037530A1 (en) 2018-08-22 2020-02-27 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Crystalline form of compound and uses thereof in medicine
CN111449050A (zh) 2019-01-20 2020-07-28 睿诺医疗科技(上海)有限公司 环孢菌素类似物及其用途
CN116870135A (zh) 2019-10-12 2023-10-13 睿诺医疗科技(上海)有限公司 肾毒素诱发的肾损伤的治疗和预防
CA3172535A1 (en) 2020-03-26 2021-09-30 Ching-Pong Mak Cyclophilin inhibitors and uses thereof
AU2021256222A1 (en) 2020-04-15 2022-10-06 Farsight Medical Technology (Shanghai) Co., Ltd. Prevention and treatment of organ injuries

Similar Documents

Publication Publication Date Title
TWI683810B (zh) 用於製備二芳基硫乙內醯脲化合物之方法
JP2022043078A5 (cg-RX-API-DMAC10.html)
JP7761578B2 (ja) シクロスポリン誘導体の調製
CN109678791B (zh) 1-(2,4-二氟苯)-2,2-二氟-2-(5-取代吡啶-2-基)乙酮及制备方法
JP2018531218A5 (cg-RX-API-DMAC10.html)
JP2017519796A5 (cg-RX-API-DMAC10.html)
JP2022116171A5 (cg-RX-API-DMAC10.html)
JPS5946222B2 (ja) グアニジン化合物の製法
JP3140747B2 (ja) 新規il−1阻害剤の合成に有用なフランスルホンアミド化合物の能率的な製造方法
CN1188475A (zh) 胍衍生物,其中间体及其产物的制备方法
CN106188044B (zh) 一种碘催化的3-芳硫基咪唑并[1,5-a]N-杂环化合物的合成方法
JP2006505567A5 (cg-RX-API-DMAC10.html)
JP2001514619A (ja) 置換チアゾリジンジオンの製造方法
JP2004515542A (ja) キノロン類及びナフチリジン類の製造方法における環化工程
CN1533378A (zh) 制备喹唑啉的方法
CN113845509A (zh) 吲哚基取代螺[环丁烷-1,1′-茚]类化合物的合成方法
CN1930124A (zh) 制备交叉偶联吲哚的方法
JPWO2001017968A1 (ja) 芳香族ヘテロ環誘導体を含有するインテグラーゼ阻害剤
CN109912640B (zh) 一种2-吡咯烷酮类化合物的制备方法
JP2004525927A (ja) ランソプラゾール及びその中間体の製造方法
JP2024541320A (ja) 特定のメソイオン性殺虫剤の調製プロセス
CN115315425A (zh) 一种取代的咪唑并[1,2-a]吡啶-2-基酰胺化合物的制备方法及其中间体
JPWO2021085535A5 (cg-RX-API-DMAC10.html)
CN1950384A (zh) 外消旋选择性制备柄型金属茂的方法
JP2005527566A5 (cg-RX-API-DMAC10.html)